RT Book, Section A1 Bharat, Ankit A1 Kreisel, Daniel A1 Patterson, G. Alexander A2 Sugarbaker, David J. A2 Bueno, Raphael A2 Burt, Bryan M. A2 Groth, Shawn S. A2 Loor, Gabriel A2 Wolf, Andrea S. A2 Williams, Marcia A2 Adams, Ann SR Print(0) ID 1170413432 T1 Lung Transplantation Technique T2 Sugarbaker’s Adult Chest Surgery, 3e YR 2020 FD 2020 PB McGraw-Hill Education PP New York, NY SN 9781260026931 LK accesssurgery.mhmedical.com/content.aspx?aid=1170413432 RD 2024/10/09 AB Since its inception in 1963, more than 35,000 lung transplants have been performed globally. For several decades, chronic obstructive pulmonary disease (COPD) was the most common indication for lung transplantation. However, in the United States, the donor lung allocation system has changed the scenario and interstitial lung disease (ILD) is emerging as a more common indication. ILD accounts for about 30% of lung transplants at our center and 33% nationally.1 Cystic fibrosis (CF) is the third most common indication.